SPAR Group, Inc. (SGRP) today announced its financial results for the second quarter 2012. Company revenues were $24.3 million, with gross profit of $6.7 million and net income attributable to SPAR Group, Inc. of $718,000. For the six months of 2012 SPAR achieved revenue of $45.4 million, gross profit of $12.5 million and diluted earnings […]
APS Enthusiasts, What The F* Are You Doing?
All pinky market is holding its breath – APS’s (AwesomePennyStocks) new pick is coming! Penny traders are riveting with excitment! Copycats emails are flooding traders’ mailboxes. Today, for example, Aquentium, Inc. (AQNM), as a new PennyPic alert, has been brought to you by pennymafia. AQNM stock quickly rose for over 100% gains and dropped faster […]
Implant Sciences (IMSC): TSA Certification is just Around the Corner
An upcoming review of Implant’s Quantum Sniffer ETD by the Transportation Security Administration (TSA) expected at the end of August 2012 Implant Sciences Corporation 600 Research Drive Wilmington, MA 01887 USA Tel: 978.752.1700 Fax: 978.752.1711 http://www.implantsciences.com Street Sense Video: The Transportation Security Administration The Transportation Security Administration (TSA) was created in the wake of […]
Echo Therapeutics (ECTE): Positive Results from its trial of the Symphony® tCGM System
Echo Therapeutics, Inc. (Nasdaq: ECTE) today announced positive results from its clinical trial of the Symphony® tCGM System in major general surgery and cardiothoracic surgery for critically ill patients Continuously monitored glucose levels with Symphony® tCGM in the intensive care unit at Thomas Jefferson University Hospital in Philadelphia, ECTE’s Symphony System accurately read glucose levels with a […]
Implant Sciences (IMSC): Significant ROI Ahead
Our new investment opportunity with at least 100% ROI (return on investment) in short-term is Implant Sciences Corp. (IMSC) Implant Sciences develops and manufactures explosive trace detection sensors and systems that are capable of detecting minute amounts of a wide variety of military, commercial, and homemade explosives. IMSC’s patented technologies provide unique screening capabilities to […]
New Investment Opportunity in Defense Products Company
We love stocks for companies in healthcare sector, both in biotech and medical appliances industries, especially if these companies develop or already marketing their innovative products. Your investment here, particularly at early stages, not just helps increasing the companies’ financial flexibility for developing a new world-shattering drug and/or revolutionary medical device, but also offers the […]
Trading Opportunity with Systems America, Inc. (SYAI)
Systems America, Inc. (SYAI) announced today after market hours that company received notice that Pink OTC Markets finished the processing the Company’s 2011 Annual Report and two reports for the quarters of 2012. As the result the Pink Sheets “Current Information” tier will be applied to the SYAI on July 25, 2012. Also Systems America is […]
Galectin Therapeutics (GALT): U.S. Patent for Treatment for Chronic Liver Diseases
Galectin Therapeutics (GALT) develops carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the company’s unique approach of galectin proteins, key mediators of biologic function. Galectin announced today that it has received a notice of issuance from the U.S. Patent and Trademark Office for Patent Number 8,236,780. The patent covers key […]
Lpath, Inc. (LPTN): Street Sense Video
Lpath Incorporated (LPTN) Street Sense Video: Lpath, Inc. (LPTN) is a biotechnology company focused on the discovery and development of monoclonal antibodies targeted to bioactive lipids. Lipid-based therapeutics are an emerging field of medical science whereby bioactive signaling lipids are targeted for treating important human diseases that currently lack innovative and effective medicines. Pipeline: iSONEP™ […]
Astex Pharmaceuticals (ASTX): EMA Recommends DACOGEN Approval in the EU
Astex Pharmaceuticals, Inc. (ASTX) today announced that Janssen-Cilag International NV, who holds marketing and development rights for DACOGEN™ in all markets except the North America, was notified that the CHMP (Committee for Medical Products for Human Use) of the EMA (European Medicines Agency) granted a positive opinion recommending approval of DACOGEN™ for injection in the […]